lysine has been researched along with diprenorphine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Huang, P; Li, J; Liu-Chen, LY; Visiers, I; Weinstein, H | 1 |
Haines, DS; Li, JG; Liu-Chen, LY | 1 |
2 other study(ies) available for lysine and diprenorphine
Article | Year |
---|---|
Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp.
Topics: Amino Acid Motifs; Amino Acid Substitution; Animals; Aspartic Acid; CHO Cells; Conserved Sequence; Cricetinae; Diprenorphine; Gene Expression; Guanosine 5'-O-(3-Thiotriphosphate); Lysine; Models, Molecular; Naloxone; Narcotic Antagonists; Pertussis Toxin; Rats; Receptors, Opioid, mu; Sulfur Radioisotopes; Threonine; Tritium; Virulence Factors, Bordetella | 2001 |
Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amino Acid Sequence; Animals; Arginine; CHO Cells; Cricetinae; Cricetulus; Deubiquitinating Enzyme CYLD; Diprenorphine; Down-Regulation; Endocytosis; Humans; Lysine; Molecular Sequence Data; Mutant Proteins; Mutation; Narcotic Antagonists; Phosphorylation; Polyubiquitin; Protein Structure, Tertiary; Receptors, G-Protein-Coupled; Receptors, Opioid, kappa; Tumor Suppressor Proteins; Ubiquitination | 2008 |